How to manage infections after hematopoietic stem cell transplantation and the issue of resistance
Can ibrutinib be used as a first-line treatment in CLL?
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
ABL001 – a new BCR-ABL inhibitor for chronic myeloid leukemia (CML) treatment
What we can look forward to in the world of non-Hodgkin lymphoma